Posssible new treatments for hormone-resistant prostate cancer
Thursday, December 17th, 2009 Posted in hormone therapy | No Comments »Prostate cancer patients with advanced disease are often treated with hormones. A new thesis from the Sahlgrenska Academy, at the University of Gothenburg, Sweden reveals that when the tumours start growing again they have more and different blood vessels. Late in ...
Considerations related to surgery as first-line treatment of higher-risk prostate cancers
Wednesday, December 16th, 2009 Posted in prostatectomy | No Comments »An oncology group at Memorial Sloan-Kettering Cancer Center (MSKCC) focused of the use of surgery as opposed to external beam radiation therapy as first-line therapy in patients believed to have locally advanced forms of prostate cancer. The group went on to ...
Criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer
Tuesday, December 15th, 2009 Posted in Uncategorized | No Comments »A recent study at Vita-Salute University San Raffaele, Milan, Italy. aimed to test the ability of two of the most stringent criteria used to identify patients with low-risk prostate cancer suitable for active surveillance (AS) to correctly exclude patients with ...
Aggressive recurrence after radical prostatectomy predicted by a new nomogram
Monday, December 14th, 2009 Posted in prostate cancer diagnosis | No Comments »Researchers associated with the Duke Prostate Cancer, Durham, NC, USA, have re-calibrated an older nomogram used to predict the likelihood of biochemical recurrence after a radical prostatectomy. The revised nomogram is now capable of predicting not only biochemical recurrence but ...
The future is robotic surgery
Sunday, December 13th, 2009 Posted in prostatectomy | No Comments »Robotic surgery represents an evolution in technology. Improvements in surgical instrumentation and optics enhance the surgical capabilities by providing superior visualization, enhanced dexterity and greater surgical precision. The da Vinci Robot is used as an extension of the operating surgeon. ...
Androgen deprivation therapy associated to higher risk for diabetes and heart disease
Saturday, December 12th, 2009 Posted in hormone therapy | No Comments »According to a new study published online December 7 in the Journal of the National Cancer Institute, men of all ages treated for prostate cancer with androgen deprivation therapy, specifically with gonadotropin-releasing hormone agonists (GnRH), have an increased risk of ...
Should prostate specific antigen be adjusted for body mass index?
Friday, December 11th, 2009 Posted in prostate cancer | No Comments »According to a report by Dr. Stacy Loeb and colleagues from Johns Hopkins University and the National Institute on Aging, the impact of body mass index (BMI) on PSA levels is small. Several studies have suggested a correlation between increased BMI ...
Glucose can help in preventing low sodium levels in patients undergoing prostate surgery
Thursday, December 10th, 2009 Posted in prostatectomy | No Comments »Excessive fluid absorption that may occur in men undergoing prostate surgery, can lead to dangerously low sodium levels. A study in the December issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS), reports that adding ...
Recent advances in prostate cancer imaging may improve the outcome of salvage therapies
Wednesday, December 9th, 2009 Posted in prostate cancer | No Comments »Because prostate cancer local recurrences can be efficiently treated by salvage therapies, it becomes critical to detect them early. Local recurrences after RP are treated by radiotherapy, those after radiotherapy by RP, cryotherapy, brachytherapy or HIFU ablation. Recurrences after cryotherapy or ...
Coffee may ‘reduce risk’ of lethal prostate cancer
Tuesday, December 8th, 2009 Posted in prostate cancer risks | No Comments »A study of almost 50,000 men found those who drank the most coffee were 60 per cent less likely to develop the most aggressive form of the disease than those who never touched the drink. The researchers from Harvard Medical School ...